Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Revenue | $991.3M | $958.4M | $1.1B | $1.4B | $1.6B | |
Revenue Growth (YoY) | 12.26% | -3.32% | 17.1% | 25.82% | 15.48% | |
Cost of Revenues | $655.5M | $623.9M | $690.9M | $896.6M | $1B | |
Gross Profit | $335.9M | $334.5M | $431.4M | $515.4M | $607.8M | |
Gross Profit Margin | 33.88% | 34.9% | 38.44% | 36.5% | 37.27% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $198.8M | $174M | $226.3M | $267M | $318.5M | |
Other Inc / (Exp) | $9.4M | $14M | -$4.5M | $960K | $4.3M | |
Operating Expenses | $250.7M | $224.5M | $275.5M | $323.3M | $369M | |
Operating Income | $85.1M | $110M | $155.9M | $192.2M | $238.8M | |
Net Interest Expenses | $11.4M | $8.7M | $4.8M | $3M | $5.2M | |
EBT. Incl. Unusual Items | $83.1M | $115.3M | $146.6M | $190.1M | $237.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $15.2M | $25.6M | $31.9M | $47.6M | $53.5M | |
Net Income to Company | $67.7M | $89.5M | $114.8M | $143M | $184.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $67.7M | $89.5M | $114.8M | $143M | $184.6M | |
Basic EPS (Cont. Ops) | $0.39 | $0.52 | $0.68 | $0.86 | $1.11 | |
Diluted EPS (Cont. Ops) | $0.39 | $0.52 | $0.67 | $0.85 | $1.10 | |
Weighted Average Basic Share | $171.8M | $171.4M | $167.7M | $166.7M | $166.3M | |
Weighted Average Diluted Share | $173.7M | $172.8M | $171.2M | $169.2M | $168.2M | |
EBITDA | $176.2M | $204.2M | $229.6M | $276.4M | $321.8M | |
EBIT | $96.7M | $126.5M | $154.1M | $198.4M | $251.1M | |
Revenue (Reported) | $991.3M | $958.4M | $1.1B | $1.4B | $1.6B | |
Operating Income (Reported) | $85.1M | $110M | $155.9M | $192.2M | $238.8M | |
Operating Income (Adjusted) | $96.7M | $126.5M | $154.1M | $198.4M | $251.1M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $241M | $290.3M | $361.4M | $411M | $472.1M | |
Revenue Growth (YoY) | -4.13% | 20.46% | 24.46% | 13.73% | 14.87% | |
Cost of Revenues | $152.1M | $177.7M | $230.5M | $256M | $293.8M | |
Gross Profit | $88.9M | $112.6M | $130.9M | $155M | $178.3M | |
Gross Profit Margin | 36.9% | 38.78% | 36.22% | 37.71% | 37.76% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $42.1M | $57.8M | $66.4M | $83.2M | $95.1M | |
Other Inc / (Exp) | $2.4M | -$10.7M | $2.3M | -$919K | $2.1M | |
Operating Expenses | $54.5M | $70.1M | $80.8M | $94.7M | $108.9M | |
Operating Income | $34.4M | $42.4M | $50.1M | $60.2M | $69.4M | |
Net Interest Expenses | $1.9M | $1M | $985K | $1.3M | $3M | |
EBT. Incl. Unusual Items | $35M | $30.7M | $51.4M | $58M | $68.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $8.5M | $4.2M | $12.4M | $14.2M | $15.5M | |
Net Income to Company | $26.4M | $26.5M | $39.1M | $43.9M | $53M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $26.4M | $26.5M | $39.1M | $43.9M | $53M | |
Basic EPS (Cont. Ops) | $0.15 | $0.16 | $0.24 | $0.26 | $0.33 | |
Diluted EPS (Cont. Ops) | $0.15 | $0.15 | $0.23 | $0.26 | $0.33 | |
Weighted Average Basic Share | $171.6M | $167.2M | $166.2M | $166.2M | $161.7M | |
Weighted Average Diluted Share | $172.7M | $171.5M | $168.9M | $167.7M | $163.2M | |
EBITDA | $56.8M | $51.3M | $73.5M | $88.1M | $104M | |
EBIT | $37.6M | $32.5M | $53.9M | $61.4M | $74.1M | |
Revenue (Reported) | $241M | $290.3M | $361.4M | $411M | $472.1M | |
Operating Income (Reported) | $34.4M | $42.4M | $50.1M | $60.2M | $69.4M | |
Operating Income (Adjusted) | $37.6M | $32.5M | $53.9M | $61.4M | $74.1M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $966.4M | $1.1B | $1.3B | $1.6B | $1.8B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $641.4M | $658.1M | $842.9M | $998.1M | $1.1B | |
Gross Profit | $324.9M | $417.7M | $490M | $593.2M | $659.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $178.7M | $209.7M | $258.3M | $305.3M | $361.5M | |
Other Inc / (Exp) | $12.9M | -$3.3M | $7.6M | -$2.6M | $7.7M | |
Operating Expenses | $228.5M | $259.6M | $312.8M | $357.7M | $412.8M | |
Operating Income | $96.4M | $158.1M | $177.2M | $235.5M | $246.6M | |
Net Interest Expenses | $9.4M | $6.8M | $1.2M | $6.4M | $7.5M | |
EBT. Incl. Unusual Items | $99.9M | $147.9M | $183.6M | $226.5M | $246.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $21M | $29.2M | $44.6M | $50.6M | $58.8M | |
Net Income to Company | $78.6M | $118.7M | $139.4M | $176.1M | $187.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $78.6M | $118.7M | $139.4M | $176.1M | $187.9M | |
Basic EPS (Cont. Ops) | $0.46 | $0.70 | $0.84 | $1.05 | $1.15 | |
Diluted EPS (Cont. Ops) | $0.45 | $0.69 | $0.82 | $1.04 | $1.14 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $188.5M | $234.4M | $266.8M | $316.8M | $341.8M | |
EBIT | $111.5M | $157.4M | $189.2M | $239.9M | $264.1M | |
Revenue (Reported) | $966.4M | $1.1B | $1.3B | $1.6B | $1.8B | |
Operating Income (Reported) | $96.4M | $158.1M | $177.2M | $235.5M | $246.6M | |
Operating Income (Adjusted) | $111.5M | $157.4M | $189.2M | $239.9M | $264.1M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $709.5M | $826.8M | $1B | $1.2B | $1.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $473.1M | $507.3M | $659.2M | $760.7M | $849.3M | |
Gross Profit | $236.3M | $319.5M | $378.2M | $455.9M | $507.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $127.3M | $163M | $194.9M | $233.2M | $276.2M | |
Other Inc / (Exp) | $10.8M | -$6.6M | $5.5M | $2M | $5.3M | |
Operating Expenses | $164.6M | $199.7M | $237M | $271.4M | $315.2M | |
Operating Income | $71.8M | $119.8M | $141.2M | $184.5M | $192.4M | |
Net Interest Expenses | $6.6M | $4.8M | $1.6M | $4.6M | $6.9M | |
EBT. Incl. Unusual Items | $75.9M | $108.5M | $145.5M | $181.9M | $190.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $18.4M | $22M | $34.8M | $37.8M | $43.1M | |
Net Income to Company | $57.3M | $86.5M | $111.1M | $144.3M | $147.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $57.3M | $86.5M | $111.1M | $144.3M | $147.6M | |
Basic EPS (Cont. Ops) | $0.33 | $0.51 | $0.67 | $0.86 | $0.91 | |
Diluted EPS (Cont. Ops) | $0.33 | $0.50 | $0.66 | $0.85 | $0.90 | |
Weighted Average Basic Share | $516.1M | $503.8M | $500.4M | $500.1M | $489.6M | |
Weighted Average Diluted Share | $519.3M | $515.1M | $507.5M | $505.8M | $493.9M | |
EBITDA | $142.2M | $172.5M | $209.7M | $250.1M | $265.1M | |
EBIT | $84.5M | $115.3M | $150.3M | $191.9M | $204.9M | |
Revenue (Reported) | $709.5M | $826.8M | $1B | $1.2B | $1.4B | |
Operating Income (Reported) | $71.8M | $119.8M | $141.2M | $184.5M | $192.4M | |
Operating Income (Adjusted) | $84.5M | $115.3M | $150.3M | $191.9M | $204.9M |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $119.2M | $218.5M | $135.3M | $118.7M | $137M | |
Short Term Investments | $202.2M | $184.3M | $179.4M | $179M | $153.9M | |
Accounts Receivable, Net | $171.9M | $147.6M | $194.2M | $259.2M | $308.1M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $19.5M | $20.9M | $31.3M | $25.8M | $43.3M | |
Other Current Assets | $2.8M | $2.9M | $2.1M | $5.9M | $4.4M | |
Total Current Assets | $541.3M | $609.3M | $578.1M | $612.8M | $679.7M | |
Property Plant And Equipment | $165.5M | $184.8M | $162.7M | $138.2M | $165.2M | |
Long-Term Investments | $4.5M | $3.2M | $3.2M | $34.8M | $4.4M | |
Goodwill | $349.5M | $349.1M | $403.9M | $405.6M | $405.6M | |
Other Intangibles | $74M | $59.6M | $81.1M | $64.8M | $50.2M | |
Other Long-Term Assets | $7.2M | $5M | $4.4M | $5.9M | $10.3M | |
Total Assets | $1.2B | $1.2B | $1.3B | $1.3B | $1.4B | |
Accounts Payable | $6.6M | $7M | $5.6M | $7.8M | $5.1M | |
Accrued Expenses | $54.6M | $49.2M | $53.3M | $54.8M | $68.4M | |
Current Portion Of Long-Term Debt | $40.9M | $25M | $260M | $30M | $65M | |
Current Portion Of Capital Lease Obligations | $24.4M | $19.1M | $18.6M | $15M | $12.8M | |
Other Current Liabilities | $9.9M | $6.4M | $9M | $20.2M | $23.9M | |
Total Current Liabilities | $229.3M | $221.1M | $495.7M | $277.9M | $326.4M | |
Long-Term Debt | $194.1M | $202M | -- | $220M | $135M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $513.1M | $528.7M | $589.7M | $587.9M | $552.5M | |
Common Stock | $39K | $39K | $40K | $200K | $203K | |
Other Common Equity Adj | -$84.9M | -$75M | -$89.5M | -$144.1M | -$127M | |
Common Equity | $670M | $719.2M | $693.2M | $758.2M | $889.4M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $670M | $719.2M | $693.2M | $758.2M | $889.4M | |
Total Liabilities and Equity | $1.2B | $1.2B | $1.3B | $1.3B | $1.4B | |
Cash and Short Terms | $321.4M | $402.8M | $314.8M | $297.7M | $290.8M | |
Total Debt | $235M | $227M | $260M | $250M | $200M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $206.4M | $114.6M | $89.3M | $122.7M | $150.1M | |
Short Term Investments | $156.2M | $169.7M | $172.9M | $151.6M | $175.6M | |
Accounts Receivable, Net | $155M | $192.2M | $256.9M | $303.4M | $176.4M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $11.9M | $32.3M | $34.6M | $43M | $53M | |
Other Current Assets | $2.5M | $2.2M | $2.3M | $3.6M | $3.7M | |
Total Current Assets | $565.1M | $545.2M | $580.6M | $651.6M | $767.7M | |
Property Plant And Equipment | $190M | $165.2M | $141.9M | $153.5M | $179.2M | |
Long-Term Investments | $4.9M | $3.1M | $34.7M | $5.3M | $14.2M | |
Goodwill | $348.7M | $348.7M | $405.8M | $405.6M | $427.7M | |
Other Intangibles | $62.9M | $49.8M | $69M | $53.3M | $51.3M | |
Other Long-Term Assets | $6.5M | $5M | $5.7M | $8M | $11.6M | |
Total Assets | $1.2B | $1.2B | $1.3B | $1.4B | $1.6B | |
Accounts Payable | $6.2M | $2.9M | $3.5M | $3.2M | $4.1M | |
Accrued Expenses | $51.9M | $44.5M | $52M | $59M | $69.6M | |
Current Portion Of Long-Term Debt | $10.5M | $15M | $35M | $50M | $4.9M | |
Current Portion Of Capital Lease Obligations | $19.3M | $18.5M | $16.9M | $14M | $16.9M | |
Other Current Liabilities | $10.7M | $11.2M | $27.4M | $29.6M | $10.9M | |
Total Current Liabilities | $184.9M | $222.9M | $287M | $306.1M | $254.2M | |
Long-Term Debt | $216.2M | $170M | $235M | $160M | $339.8M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $509.6M | $483.1M | $614.1M | $546.4M | $702.3M | |
Common Stock | $39K | $39K | $40K | $202K | $205K | |
Other Common Equity Adj | -$85.2M | -$92.3M | -$154.2M | -$136.8M | -$122.6M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $709.9M | $685M | $704.6M | $856.1M | $907.6M | |
Total Liabilities and Equity | $1.2B | $1.2B | $1.3B | $1.4B | $1.6B | |
Cash and Short Terms | $362.6M | $284.3M | $262.2M | $274.2M | $325.8M | |
Total Debt | $226.7M | $185M | $270M | $210M | $344.7M |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $67.7M | $89.5M | $114.8M | $143M | $184.6M | |
Depreciation & Amoritzation | $79.5M | $77.7M | $75.5M | $78.1M | $70.7M | |
Stock-Based Compensation | $26.1M | $28.2M | $38.6M | $49.4M | $58.4M | |
Change in Accounts Receivable | -$7.1M | $24.7M | -$37.7M | -$68.1M | -$49.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $168.4M | $203M | $184.4M | $166.1M | $211.2M | |
Capital Expenditures | $40.5M | $42.2M | $37.2M | $44.8M | $52.8M | |
Cash Acquisitions | -$241K | -$700K | -$76.8M | -$3.9M | -$600K | |
Cash From Investing | -$51.4M | -$18.3M | -$114.3M | -$96.5M | -$12M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $46M | $110M | $300M | $35M | $80M | |
Long-Term Debt Repaid | -$98.6M | -$121.1M | -$329.2M | -$45.1M | -$130.2M | |
Repurchase of Common Stock | -$41.4M | -$79.9M | -$118.4M | -$72.6M | -$131.8M | |
Other Financing Activities | -$117K | -- | -- | -- | -$5M | |
Cash From Financing | -$93.1M | -$89.6M | -$146.9M | -$81.7M | -$181.5M | |
Beginning Cash (CF) | $104.1M | $127M | $225.5M | $143.8M | $125.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $24M | $95.1M | -$76.8M | -$12.1M | $17.8M | |
Ending Cash (CF) | $127M | $225.5M | $143.8M | $125.6M | $145.4M | |
Levered Free Cash Flow | $127.9M | $160.7M | $147.1M | $121.3M | $158.4M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $26.4M | $26.5M | $39.1M | $43.9M | $53M | |
Depreciation & Amoritzation | $19.2M | $18.8M | $19.6M | $26.7M | $29.9M | |
Stock-Based Compensation | $8.3M | $10.9M | $12.2M | $17.1M | $21.2M | |
Change in Accounts Receivable | $3.7M | -$10.7M | -$21.7M | -$18.1M | -$8.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $67.4M | $59.8M | $48.1M | $68.6M | $110.1M | |
Capital Expenditures | $12.3M | $9.1M | $7M | $15M | $12.9M | |
Cash Acquisitions | -- | -- | -$750K | -$600K | -$25.1M | |
Cash From Investing | $10M | -$33.2M | -$34.2M | -$348K | -$51.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $200M | -- | -- | $110M | |
Long-Term Debt Repaid | -$10.2M | -$230.1M | -$15M | -$10M | -$100.1M | |
Repurchase of Common Stock | -$24.9M | -$28.2M | -$11.5M | -$29.9M | -$35.2M | |
Other Financing Activities | -- | -- | -- | -- | -$593K | |
Cash From Financing | -$35.1M | -$57.7M | -$26.6M | -$39.1M | -$24.9M | |
Beginning Cash (CF) | $170.8M | $157.5M | $115.2M | $98.6M | $121.7M | |
Foreign Exchange Rate Adjustment | $2.9M | -$2.8M | -$4.3M | -$1.8M | $3.2M | |
Additions / Reductions | $42.3M | -$31.1M | -$12.7M | $29.1M | $34.1M | |
Ending Cash (CF) | $216M | $123.7M | $98.3M | $128M | $163.3M | |
Levered Free Cash Flow | $55.1M | $50.7M | $41M | $53.6M | $97.3M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $78.6M | $118.7M | $139.4M | $176.1M | $187.9M | |
Depreciation & Amoritzation | $77.1M | $77.1M | $77.6M | $71.9M | $72.6M | |
Stock-Based Compensation | $25.4M | $36.2M | $46.6M | $55.6M | $72.6M | |
Change in Accounts Receivable | $25.5M | -$36.3M | -$60.9M | -$46.5M | -$31.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $188.8M | $190.4M | $171.7M | $197.2M | $242.2M | |
Capital Expenditures | $42.7M | $36.6M | $40.3M | $53.8M | $47.9M | |
Cash Acquisitions | -$700K | -- | -$80.2M | -$1.2M | -$25.1M | |
Cash From Investing | -$19M | -$50.9M | -$167.9M | -$9.9M | -$117.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $110M | $225M | $110M | $70M | $300M | |
Long-Term Debt Repaid | -$131.1M | -$329.7M | -$25.2M | -$130.2M | -$165.3M | |
Repurchase of Common Stock | -$44.4M | -$126.7M | -$104.4M | -$101.5M | -$227.2M | |
Other Financing Activities | -- | -- | -- | -- | -$4.6M | |
Cash From Financing | -$63.8M | -$230.2M | -$19.6M | -$160.9M | -$92.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $106M | -$90.7M | -$15.9M | $26.4M | $31.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $146.1M | $153.8M | $131.4M | $143.4M | $194.3M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $57.3M | $86.5M | $111.1M | $144.3M | $147.6M | |
Depreciation & Amoritzation | $57.7M | $57.2M | $59.4M | $53.2M | $55.1M | |
Stock-Based Compensation | $20.9M | $28.8M | $36.8M | $43M | $57.2M | |
Change in Accounts Receivable | $16.1M | -$44.9M | -$68.1M | -$46.5M | -$28.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $126.3M | $113.8M | $101.1M | $132.2M | $163.2M | |
Capital Expenditures | $34.6M | $29M | $32.1M | $41.1M | $36.2M | |
Cash Acquisitions | -$700K | -- | -$3.3M | -$600K | -$25.1M | |
Cash From Investing | $11.1M | -$21.5M | -$75.2M | $11.4M | -$94.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $110M | $225M | $35M | $70M | $290M | |
Long-Term Debt Repaid | -$120.6M | -$329.2M | -$25.1M | -$110.1M | -$145.2M | |
Repurchase of Common Stock | -$38.9M | -$85.6M | -$71.7M | -$100.5M | -$195.9M | |
Other Financing Activities | -- | -- | -- | -$5M | -$4.6M | |
Cash From Financing | -$48.4M | -$189.1M | -$61.8M | -$141M | -$52.2M | |
Beginning Cash (CF) | $531.4M | $567.8M | $374.1M | $319.2M | $384.3M | |
Foreign Exchange Rate Adjustment | $20K | -$5M | -$9.6M | -$288K | $1.3M | |
Additions / Reductions | $88.9M | -$96.8M | -$35.9M | $2.6M | $16.5M | |
Ending Cash (CF) | $620.3M | $465.9M | $328.5M | $321.5M | $402.2M | |
Levered Free Cash Flow | $91.7M | $84.7M | $69M | $91.1M | $127M |
Signup to receive the latest stock alerts
2024 was another banner year for the US stock market,…
Carlos Slim made a splash in a surprising sector last…
There is a lot of humdrum in the market about…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.4T
P/E Ratio: 116x
Market Cap: $3.1T
P/E Ratio: 35x
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Banco Macro SA [BMA] is up 0.88% over the past day.
Agrify [AGFY] is down 5.86% over the past day.